Is rhabdomyosarcoma cancer curable?
Sometimes treatments can cure rhabdomyosarcoma. This is called remission, which means that cancer can no longer be detected. In many cases, remission is permanent, but rhabdomyosarcoma can come back.
What is the origin of rhabdomyosarcoma?
Rhabdomyosarcoma is a malignant tumor of striated muscle origin. According to Rubin, it is derived from primitive mesenchyme that retained its capacity for skeletal muscle differentiation.
What are early signs of rhabdomyosarcoma?
Symptoms
- Persistent lump or swelling in the body that may be painful.
- Bulging of the eye or a drooping eyelid.
- Headache and nausea.
- Trouble urinating or having bowel movements.
- Blood in the urine.
- Earache or sinus infection symptoms.
- Bleeding from the nose, throat, vagina, or rectum.
- Vomiting, abdominal pain, constipation.
What is rhabdomyosarcoma?
There are many types of sarcomas. Rhabdomyosarcoma (RMS) is a type of sarcoma made up of cells that normally develop into skeletal (voluntary) muscles. These are muscles that we control to move parts of our body. Well before birth, cells called rhabdomyoblasts (which will eventually form skeletal muscles) begin to form.
What is the prognosis of rhabdomyosarcoma (RMS)?
RMS can occur at any age, but it most often affects children. Although RMS can arise anywhere in the body, it’s more likely to start in the: The outlook (prognosis) and treatment decisions depend on the type of rhabdomyosarcoma, where it starts, tumor size and whether the cancer has spread.
What are the treatment options for rhabdomyosarcoma?
Treatment of rhabdomyosarcoma is based on risk stratification, which includes histologic classification, presurgical stage, and postsurgical clinical group. Treatment modalities include surgery, chemotherapy, and radiotherapy.
What is spindle cell rhabdomyosarcoma in adults?
Review[Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues]. [Pathologe. 2010] Review[Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].